Upadacitinib monotherapy versus methotrexate monotherapy in patients with rheumatoid arthritis: efficacy and safety through 5 years in the SELECT-EARLY randomized controlled trial

Abstract Background To evaluate the efficacy and safety of upadacitinib monotherapy versus methotrexate (MTX) monotherapy over 5 years among MTX-naïve patients with moderately to severely active rheumatoid arthritis (RA) in the long-term extension (LTE) of the phase 3 SELECT-EARLY trial. Methods Pat...

詳細記述

書誌詳細

主要な著者:	Ronald van Vollenhoven, Vibeke Strand, Tsutomu Takeuchi, Nilmo Chávez, Pablo Mannucci Walter, Atul Singhal, Jerzy Swierkot, Nasser Khan, Xianwei Bu, Yihan Li, Sara K. Penn, Heidi S. Camp, Jacob Aelion
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2024-07-01
シリーズ:	Arthritis Research & Therapy
主題:	JAK inhibitor Methotrexate Targeted synthetic DMARD Upadacitinib Rheumatoid arthritis Randomized controlled trial
オンライン･アクセス:	https://doi.org/10.1186/s13075-024-03358-x
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!